Palmitoylethanolamide (PEA), a natural substance present in the human body as well as in many commonly used foods, also plays an important role in the innervated structures of the eye as a biological modulator of mast cell hyper-degranulation resulting from neuronal suffering; this function consequently leads to neuroprotection by physiologically counteracting the onset and progression of neurodegenerative phenomena associated with numerous pathological conditions such as glaucoma, ocular hypertension, and dysmetabolic or degenerative optic neuropathy. In such cases, it is useful to physiologically counteract, with the administration of Visimast 600 mg, the deficit of endogenous Palmitoylethanolamide production that occurs when the body, subjected to recurrent neuroinflammatory conditions, exhausts its natural synthesis capacity.

Directions for use
Use under medical supervision, with an indicative dosage of 1-2 tablets per day.

Warnings
The product is not suitable as a sole source of nutrition. Keep out of reach of children under 3 years of age. The use of the product during pregnancy is not recommended.

Format
20 tablets, 600 mg.

Code.8031